Rigel Pharmaceuticals, Inc.RIGLNASDAQ
LOADING
|||
Operating Income Scaling
Trending higher, above historical average.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$24.19M
↑ 155% above average
Average (9y)
$-43.62M
Historical baseline
Range
High:$24.19M
Low:$-79.62M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $24.19M | +218.1% |
| 2023 | $-20.49M | +63.1% |
| 2022 | $-55.55M | -344.5% |
| 2021 | $-12.50M | +56.9% |
| 2020 | $-28.97M | +58.1% |
| 2019 | $-69.09M | +4.9% |
| 2018 | $-72.68M | +8.7% |
| 2017 | $-79.62M | -14.2% |
| 2016 | $-69.74M | -34.8% |
| 2015 | $-51.74M | - |